Skip to main content

Grants and Funding: Funding News & Training

Search for grants and funding opportunities or research previously funded projects. Coverage includes governmental agencies and private funders.

2/1/2019 NCI Funding Update: Early Stage Investigators (MERIT R37)

NCI confirmed the FY19 Budget and in addition to the Cancer Moonshot funding, funding for early stage investigators via the Method to Extend Research in Time (MERIT)(R37) Award, which provides longer term grant support to Early Stage Investigators (ESIs) beginning with new, competing awards issued in FY2018. 

  • Eligibility: early stage investigators who have submitted a single-PI R01 application that received a score within the NCI payline are eligible for consideration; investigators may not apply for an ESI MERIT award – NCI program staff members will identify eligible candidates for the award and submit them to the National Cancer Advisory Board (NCAB) for consideration.
  • Timeframe: eligible investigators may obtain up to 7 years of support in two segments: an initial 5-year award and an opportunity for an extension of up to 2 additional years, based on an expedited NCI review of the accomplishments during the initial funding segment.

For more info visit:

NIH - Open Mike Blog

This is the blog of Dr. Michael Lauer.  Dr. Lauer is NIH's Deputy Director for Extramural Research, serving as the principal scientific leader and advisor to the NIH Director on the NIH extramural research program.

Loading ...

NIH PodCast "All About Grants"

Loading ...

NIH Tips for Applicants

NIH Extramural Nexus Blog

Loading ...


Subject Guide

Arnold Library's picture
Arnold Library
Weintraub Building
Mailstop: B1-010